The global biohacking market, valued at USD 23.63 billion in 2024, is projected to reach USD 28.73 billion in 2025 and USD 137.37 billion by 2035, representing a CAGR of 16.9% during the forecast period. As more market players continue to accelerate innovation in this field, we believe the global biohacking industry will continue to expand at a steady rate during the forecast period.

The global non-invasive aesthetic treatment market is estimated to grow from USD 26.24 billion in 2024 to reach USD 30.22 billion in 2025 and USD 86.08 billion by 2035, representing a CAGR of 11.0% during the forecast period. Non-invasive aesthetic treatment industry is experiencing remarkable growth and stands to continue the expansion in upcoming years.

The global immuno-oncology drugs market, valued at USD 80.82 billion in 2024, is projected to reach USD 97.52 billion in 2025 and USD 442.26 billion by 2035, representing a CAGR of 16.3% during the forecast period. Driven by the ongoing initiatives and accelerated approval, we believe that immuno-oncology drugs market will continue to grow at a steady pace during the forecast period.

The global animal genetics market size, valued at USD 6.89 billion in 2024, is expected to grow to USD 7.41 billion in 2025 and USD 13.45 billion by 2035, representing a CAGR of 6.1% during the forecast period. With availability of molecular technologies, such as next generation sequencing, CRISPR-Cas9, polymerase chain reaction and genome editing tools, researchers can significantly gain better insight on genes and modify them to develop a desired animal breed with high nutritional value. Furth...

The global iron deficiency anemia treatment market, valued at USD 4.66 billion in 2024, is projected to reach USD 5.09 billion in 2025 and USD 10.71 billion by 2035, representing a CAGR of 7.7% during the forecast period. According to our iron deficiency anemia treatment market report, presently parenteral iron therapy segment accounts for the largest share (60%) of the market.

The global sickle cell disease market size, valued at USD 3.02 billion in 2024, is projected to reach USD 3.63 billion in 2025 and USD 16.01 billion by 2035, representing a CAGR of 16.0% during the forecast period. Driven by the ongoing initiatives, we believe that the sickle cell disease treatment market is expected to grow at a steady rate during the forecast period, offering lucrative opportunities to drug developers for investments.

The global astaxanthin market size, valued at USD 2.52 billion in 2024, is projected to reach USD 2.83 billion in 2025 and USD 7.57 billion by 2035, representing a CAGR of 10.3% during the forecast period. According to our astaxanthin market report, presently North America accounts for the highest share of the market.

The nutraceutical product testing market size is estimated to be USD 2.93 billion in 2025 and is projected to reach USD 7.33 billion by 2035. The market is anticipated to grow at a CAGR of 9.6%, during the forecast period, till 2035. In 2024, around 2 million new cancer cases and 611,720 deaths due to cancer have been reported in the US, with a significant rise in cancer rate predicted in the coming years. Currently, the analytical testing segment captures the maximum share (32%) in the overall...

The global epigenomics market, valued at USD 1.98 billion in 2024, is projected to reach USD 2.32 billion in 2025 and USD 8.49 billion by 2035, representing a CAGR of 13.8% during the forecast period. With growing usage across healthcare industry, various industrial players are focusing on the development of advanced products, instruments, and services.

The global RNAi drug delivery market, valued at USD 103.23 billion in 2024, is projected to reach USD 134.0 billion in 2025 and USD 818.45 billion by 2035, representing a CAGR of 19.8% during the forecast period. According to our RNAi drug delivery market report, presently siRNA segment accounts for the largest share of the market.

The global hair transplant market size is valued at USD 8.01 billion in 2024 and is estimated to reach USD 15.65 billion by 2035, representing a CAGR of 6.28%, during the forecast period. It is important to highlight here that in March 2023, Venus Concept successfully launched the latest generation of ARTAS iX for hair transplantation, which is integrated with several technologies, such as machine learning, artificial intelligence and surgical robots. In addition to technological innovations, se...

The global cancer immunotherapy market, valued at USD 134.40 billion in 2024, is expected to grow to USD 148.73 billion in 2025 and USD 346.63 billion by 2035, anticipated to grow at a CAGR of 8.8% during the forecast period. A recent study published in National Institute of Health, in 2025, around 2,041,910 new cancer cases and nearly 618,120 cancer deaths are projected to occur in the US. In December 2024, AstraZeneca Imfinzi

The global pharmaceutical caps and closures market size is estimated to grow from USD 6.20 billion in 2024 to USD 12.49 billion by 2035, representing a higher CAGR of 6.6% during the forecast period till 2035.Caps and closures refer to the air-tight sealing products that have been designed to protect pharmaceutical drugs from moisture, dust and unfavorable climatic conditions. These caps and closures have been made using different types of materials such as metal, plastic and polymers. As per pr...

The global non-alcoholic steatohepatitis market, or NASH drugs market, is valued at USD 7.48 billion in 2024 and is poised to reach at USD 71.69 billion by 2035, representing a CAGR value of 22.8% during the forecast period. Examples of the key drug developers active in this industry (the complete list of the companies has also been included in the detailed market report) include Conatus Pharmaceuticals, Galmed Pharmaceuticals, Genfit, Gilead Sciences, Intercept Pharmaceuticals, Novo Nordisk, Ra...

The global peptide receptor radionuclide therapy market is expected to grow from USD 2.7 billion in 2025 to USD 30.1 billion by 2035, representing a CAGR of 27.43% during the forecast period. Continuous research on advanced radioligands and finding innovative delivery methods to improve efficacy and safety have become a key driver of peptide receptor radioligand therapy market. It is important to highlight here that in May 2024, the FDA has approved Lutathera

The global dental tourism market size is estimated to grow from USD 10.36 billion in 2025 to USD 41.49 billion by 2035, representing a higher CAGR of 14.9% during the forecast period. Currently, the market players in the medical tourism industry is focusing on expanding tourism services. For instance, in September 2024, EaseMyTrip.com recently announced acquisition of Pflege Home Healthcare ( acquired 49% equity stake) and Rollins International (acquiring 30% equity stake) to expand medical tour...

The global cartilage repair market, valued at USD 1.57 billion in 2024, is projected to reach USD 1.77 billion in 2025 and USD 4.77 billion by 2035, representing a CAGR of 10.3% during the forecast period. According to our projection, currently, cell-based segment holds the highest share (63%) of the cartilage repair industry.

The global theranostics market, valued at USD 2.33 billion in 2024, is projected to reach USD 2.67 billion in 2025 and USD 8.26 billion by 2035, representing a CAGR of 11.9% during the forecast period. Driven by the increasing initiatives and rising awareness among healthcare experts, we believe theranostics industry will remain progressive during the forecast period.

The global legal marijuana market, valued at USD 30.18 billion in 2024, is projected to reach USD 36.03 billion in 2025 and USD 212.39 billion by 2035, representing a CAGR of 19.41% over the forecast period. Driven by the growing research and rising usage across various industry verticals, the legal marijuana market will continue to grow at a steady rate during the forecast period.

The global radiotherapy market size, valued at USD 3.69 billion in 2024, is expected to reach USD 3.80 billion in 2025 and USD 5.0 billion by 2035, representing a CAGR of 2.78% during the forecast period. In a recent report of WHO, nearly 2.3 million women has been diagnosed with breast cancer and around 6,70,000 deaths occurred globally due to breast cancer. This increasing prevalence of cancer has underscored the requirement for advanced radiotherapy treatment with higher efficacy rate and min...